Study approval.
Arthritis, Musculoskeletal, Cancer
ARTHRITIS, SKIN DISEASES, CANCER
This early phase I clinical trial was conducted in accordance with the Declaration of Helsinki guidelines, registered on clinicaltrials.gov (NCT02968446), and approved by the IRB of Case Western Reserve University and Case Comprehensive Cancer Center (CASE 3416). All participants provided written consent prior to participation. This study was funded by the NIH and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; grants U01AR064144-01, U01AR071168, and U01AR075049).